Belluscura receives approval for X-PLOR oxygen device in Hong Kong

Belluscura, a medical device developer focused on lightweight and portable oxygen enrichment technology, has received approval from the Hong Kong Department of Health – Medical Device Division to distribute the X-PLOR portable oxygen concentrator.

The company has also successfully completed the DISCOV-R portable oxygen concentrator patient usability study with all participants providing favourable feedback on the device. Initial production of the DISCOV-R will commence this week. Full-scale production is being planned in conjunction with Innomax in response to the significant preliminary demand already received by the company.

Bob Rauker, chief executive officer, Belluscura, said: “We are very excited to receive the approval and begin sales in Hong Kong. I am very pleased with our operations, quality control and sales teams receiving approval ahead of schedule. Hong Kong is phase one of our joint expansion with Innomax into Asia.”